Grigorios Siokas - 19 May 2026 Form 4 Insider Report for Cosmos Health Inc. (COSM)

Reporting relationship: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: COSM
Reported as of: 19 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Jun 2026, 17:25:13 UTC
Prior SEC filing: 13 Feb 2026
Next SEC filing: 12 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Grigorios Siokas

Key filing fact

Grigorios Siokas filed Form 4 for Cosmos Health Inc. (COSM) on 11 Jun 2026.

Key facts

This page summarizes Grigorios Siokas's Form 4 filing for Cosmos Health Inc. (COSM).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Jun 2026, 17:25.

Change

Previous filing in this sequence was filed on 13 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001660125 Primary reporting owner

Siokas Grigorios

Relationship: Chief Executive Officer, Director, 10%+ Owner
Address: 5 AG. GEORGIOU STR., PILEA, GREECE
Signature: /s/ Grigorios Siokas
Signature date: 11 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

COSM transaction

Common Stock, par value $.001

Award

Transaction value
Shares: +2,350,000
Change %: +23%
Price: $0.2830^*
Shares after: 12,561,914
Date: 19 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

COSM transaction Derivative

Restricted Stock Unit

Conversion of derivative security

Transaction value
Shares: -2,350,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 19 May 2026
Ownership: Direct
Underlying class: Common Stock, par value $.001
Underlying amount: 2,350,000
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects the award of 2,350,000 shares of common stock granted on May 19, 2026, pursuant to the Issuer's 2024 & 2025 Omnibus Incentive Plan, in a transaction exempt under Rule 16b-3.

Footnote F2

The RSUs were granted on May 19, 2026, under the Issuer's 2024 & 2025 Omnibus Incentive Plan and vested on the date of the grant, in a transaction exempt under Rule 16b-3.